New Angiogenesis Inhibitor Has Promise For Treating Deadly Brain Tumor - News
New Angiogenesis Inhibitor Has Promise For Treating Deadly Brain Tumor
Wed, 17 Jan 2007 10:00 AM EST
... Researchers from the Massachusetts General Hospital Cancer Center have found that AZD2171, a new angiogenesis inhibitor, can significantly reduce the size of the deadly brain tumors called glioblastomas and has the potential of improving the effectiveness of other therapeutic techniques. The Phase 2 clinical trial also finds that the new drug can alleviate brain swelling (edema), a debilitating symptom in many brain cancer patients that currently can be treated only with steroid drugs. ...